|
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 491 - 500 of 2187:
FDA approves new acromegaly drug
The US Food and Drug Administration has approved the drug Somatuline Depot for treating an endocrine disorder which affects body growth. The FDA a...
FDA approves new Boston Scientific stent
Boston Scientific Corp said on Friday that U.S. health regulators have approved the next-generation version of its widely used Taxus drug-coated stent...
FDA Approves New Contraceptive Pill Lybrel
The FDA approves an oral contraceptive that also eliminates menstruation. Wyeth's oral contraceptive Lybrel is now approved by the FDA to eliminate...
FDA Approves New Drug for Severe Epilepsy
A new drug called Banzel (rufinamide) has been approved as a supplementary treatment for a severe form of epilepsy called Lennox-Gastaut syndrome, the...
FDA approves new extended release painkiller
The FDA has approved Ryzolt (tramadol HCl extended-release tablets), a once-daily formulation of the analgesic tramadol. Ryzolt is indicated for the m...
FDA Approves New Formulation For OxyContin To Discourage Misuse And Abuse.
The US Food and Drug Administration will begin requiring device manufacturers to provide information in certain premarket applications regarding “pedi...
FDA Approves New Gout Medicine
For the first time in more than forty years there's a new medication receiving FDA approval for the treatment of gout. That often affects one joint, w...
FDA approves new HIV blood test from Roche
Federal regulators said Tuesday they have approved a new HIV test that screens for two, less common forms of the virus.The Food and Drug Administratio...
FDA approves new injection site for Risperdal
Alkermes Inc. said Thursday a long-acting version of its schizophrenia drug Risperdal has been approved for arm injection by U.S. health regulators. T...
FDA approves new labeling for psoriasis drug Raptiva
The U.S. Food and Drug Administration today announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infectio... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |